IFN-gamma deficiency worsen Pneumocystis pneumonia with Th17 development in nude mice.

[1]  E. Medina,et al.  Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia. , 2009, Diagnostic microbiology and infectious disease.

[2]  D. Cooper,et al.  Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over‐active CD4+ T‐cell responses in HIV‐positive patients with mycobacterial immune restoration disease , 2009, European journal of immunology.

[3]  I. James,et al.  Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis , 2008, HIV medicine.

[4]  M. McGeachy,et al.  Review Th17 Cell Differentiation: the Long and Winding Road , 2022 .

[5]  Francesco Bistoni,et al.  IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance , 2007, European journal of immunology.

[6]  J. Shellito,et al.  Interleukin-23 (IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection , 2007, Infection and Immunity.

[7]  J. Kolls,et al.  Regulatory T Cells Dampen Pulmonary Inflammation and Lung Injury in an Animal Model of Pneumocystis Pneumonia1 , 2006, The Journal of Immunology.

[8]  R. Escamilla,et al.  Pneumocystis jirovecii genotypes and granulomatous pneumocystosis. , 2006, Medecine et maladies infectieuses.

[9]  E. Vicaut,et al.  Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients , 2006, AIDS.

[10]  J. Cleland,et al.  The key lesson of family planning programmes for HIV/AIDS control , 2006, AIDS.

[11]  S. Ziegler,et al.  FOXP3 acts as a rheostat of the immune response , 2005, Immunological reviews.

[12]  T. Matsuguchi,et al.  Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia. , 2005, Microbes and infection.

[13]  M. Battegay,et al.  Immune reconstitution in HIV-infected patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Lau,et al.  Clinical Spectrum of Paradoxical Deterioration During Antituberculosis Therapy in Non-HIV-Infected Patients , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  U. Prakash.  Granulomatous Pneumocystis carinii pneumonia in patients with malignancy. , 2002 .

[16]  G. Janossy,et al.  Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV‐infected subjects , 2002, HIV medicine.

[17]  J. Demengeot,et al.  CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. , 2002, European journal of immunology.

[18]  M. Rosen,et al.  Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop. , 2001, American journal of respiratory and critical care medicine.

[19]  A. Billiau,et al.  Bimodal role of endogenous interleukin‐6 in concanavalin A‐induced hepatitis in mice , 2000, Journal of leukocyte biology.

[20]  L. Brochard,et al.  Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  D. Kachel,et al.  Gamma Interferon Stimulates Rat Alveolar Macrophages To Kill Pneumocystis carinii byl-Arginine- and Tumor Necrosis Factor-Dependent Mechanisms , 1999, Infection and Immunity.

[22]  R. Brunham,et al.  IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. , 1999, Journal of immunology.

[23]  Y. Iwakura,et al.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.

[24]  B. Garvy,et al.  Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection , 1997, Infection and immunity.

[25]  K. Takatsu,et al.  Occurrence of interleukin-5 production by CD4- CD8- (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canis. , 1995, Immunology.

[26]  K. Sugane,et al.  Mechanisms of eosinophilia in Toxocara canis infected mice: In vitro production of interleukin 5 by lung cells of both normal and congenitally athymic nude mice , 1993, Parasite immunology.

[27]  C. Sidman,et al.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. , 1992, The Journal of clinical investigation.

[28]  J. Kennedy,et al.  Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. , 1992, Journal of immunology.

[29]  H. D. Liggitt,et al.  Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon , 1991, Infection and immunity.

[30]  A. Harmsen,et al.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice , 1990, The Journal of experimental medicine.

[31]  J. Phair,et al.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. , 1990, The New England journal of medicine.

[32]  H. Shear,et al.  Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-gamma and reduced doses of trimethoprim/sulfamethoxazole. , 1990, Journal of Acquired Immune Deficiency Syndromes.

[33]  E. Pesanti.  Pneumocystis carinii: oxygen uptake, antioxidant enzymes, and susceptibility to oxygen-mediated damage , 1984, Infection and immunity.

[34]  K. Yoneda,et al.  Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice , 1979, Infection and immunity.